CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

News Releases

News Releases

CV Sciences, Inc. to Present and Exhibit as Silver Sponsor at Natural Products Expo West 2018 in Anaheim, California, March 7-11, 2018

Company enters its 3rd year sponsoring and exhibiting at the nation’s largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings LAS VEGAS, NV–(GlobeNewswire – February 13, 2018) – CV Sciences, Inc. (OTCQB: CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced … Continue reading CV Sciences, Inc. to Present and Exhibit as Silver Sponsor at Natural Products Expo West 2018 in Anaheim, California, March 7-11, 2018

CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018

Company Continues Targeting the Broad Network of Healthcare Practitioners focused on Integrative and Nutritional Modalities LAS VEGAS, NV– (Globe Newswire – January 24, 2018) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), today announced that it will be exhibiting its industry-dominating brand of hemp-derived CBD oil finished products, PlusCBD Oil™, … Continue reading CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

Company Avoids Dilution to Stockholders Las Vegas, NV – (Globe Newswire – January 16, 2018) – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the January 2018 installment obligation under its March 1, 2017 Convertible Promissory Note (the “Note”) in cash, thus avoiding the lender’s conversion … Continue reading CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

CV Sciences, Inc. to Present at the Biotech Showcase™ 2018

LAS VEGAS, NV, January 3, 2018– CV Sciences, Inc., (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”), preeminent supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil and developer of specialty pharmaceutical therapeutics, announced today that it will be presenting at the Biotech Showcase™ 2018. The conference will be held January 8-10, 2018 at the … Continue reading CV Sciences, Inc. to Present at the Biotech Showcase™ 2018

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

Company Avoids Dilution to Stockholders Las Vegas, NV – (Globe Newswire – December 5, 2017) – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation under its March 1, 2017 Convertible Promissory Note (the “Note”) in cash, thus avoiding the lender’s conversion … Continue reading CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

CV Sciences, Inc. to Present at the 10th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 28, 2017 / CV Sciences, Inc., (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical therapeutics, announced today that it will be presenting at the 10th annual LD Micro Main Event on Wednesday, December 6th at 10:30 AM PST / 1:30 PM EST … Continue reading CV Sciences, Inc. to Present at the 10th Annual LD Micro Main Event

CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL – December 1-3, 2017

Company enters its 3rd year exhibiting its industry-dominating brand, PlusCBD Oil™ at the Southeastern Regional Natural Health Retailer Conference and Expo. LAS VEGAS, NV — (Globe Newswire – November 21, 2017) – CV Sciences, Inc. (OTCBB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry dominating brand of finished … Continue reading CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL – December 1-3, 2017

CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

Award recognizes 500 of the fastest growing companies in North America from 2013 to 2016 LAS VEGAS, NV – November 14, 2017 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical therapeutics, announced it has been named on Deloitte’s Technology Fast … Continue reading CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

– Record Quarter for all Financial Performance Metrics – Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results Las Vegas, NV – November 8, 2017 – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today its financial results for the third quarter and nine months ended … Continue reading CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

CV Sciences, Inc. Repays Convertible Debt

Company Satisfies Obligations on a Portion of its Outstanding Convertible Debt, Avoiding Dilution to Stockholders LAS VEGAS, NV — (Globe Newswire — October 17, 2017) – CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD) products and developer of specialty pharmaceutical therapeutics, announced today that … Continue reading CV Sciences, Inc. Repays Convertible Debt